Recently, it has been shown that TMED2 overexpression was negatively correlated with CD8+ T immune cell levels in HNSC, suggesting that TMED2 might initiate tumor development by altering the levels of immune infiltration in the tumor microenvironment (Sial et al., 2021). This evidence concerns the gene CD8A and neoplasm.